More than 2,000 patients tested in UK’s first routine genotyping project for clopidogrel prescribing
Exclusive: The genotyping project at NHS Tayside identified 2,300 patients, 29% of whom emerged as ‘poor’ or ‘intermediate’ CYP2C19-clopidogrel metabolisers.…